Emergent BioSolutions (EBS) Prelim. FY15 adj.-EPS Tops Views

Go back to Emergent BioSolutions (EBS) Prelim. FY15 adj.-EPS Tops Views

Emergent Biosolutions Announces Preliminary 2015 Financial Results, Provides 2016 Financial Outlook, and Outlines New Five-Year (2016-2020) Strategic Growth Plan

January 11, 2016 7:01 AM UTC

2015 Preliminary Estimates:Total revenues of $520 to $525 million, a 16% increase over 2014 (at midpoint)GAAP net income of $60 to $64 million, a 69% increase over 2014 (at midpoint)Adjusted net income of $73 to $77 million, a 38% increase over 2014 (at midpoint)EBITDA of $130 to $134 million, a 43% increase over 2014 (at midpoint)Year-end cash of approximately $310 million2016 Forecast:Total revenues of $600 to $630 millionGAAP net income of $75 to $85 millionAdjusted net income of $90 to $100 millionEBITDA of $150 to $160 million  2020 Key Financial and... More